ApiFix® Ltd. developed the ApiFix procedure, a novel treatment option to fill a gap in the treatment of adolescent idiopathic scoliosis (AIS). The procedure offers select AIS patients a less-invasive, motion-preserving option for achieving curve correction.
In 2020, ApiFix was acquired and became a wholly-owned subsidiary of OrthoPediatrics Corp. (Nasdaq: KIDS), focused exclusively on advancing the field of pediatric orthopedics and improving the lives of children with orthopedic conditions.
Bracing may be ineffective. Fusion is forever. The ApiFix® procedure offers select adolescent idiopathic scoliosis (AIS) patients a less invasive, motion-preserving option for achieving curve correction – without the permanence of fusion.